Sosei teams up with Abbvie on neurological drug discovery
Drug Discovery World
AUGUST 4, 2022
Biopharmaceutical group Sosei will work together with AbbVie on a drug discovery project to discover, develop and commercialise small molecules that target neurological diseases. . The new agreement will see Sosei Heptares conduct and fund R&D activities through the completion of Investigational New Drug (IND)-enabling studies.
Let's personalize your content